Contact
searchSearch
HMP Global

Drug Recalls News

News
Macleods Recalls Levothyroxine Sodium Tablets Due to Subpotency
04/02/2026
Hannah Musick
Macleods Pharma USA, Inc is recalling one lot of levothyroxine sodium tablets 150 mcg nationwide after testing identified subpotent drug levels that may reduce therapeutic effectiveness.
Macleods Pharma USA, Inc is recalling one lot of levothyroxine sodium tablets 150 mcg nationwide after testing identified subpotent drug levels that may reduce therapeutic effectiveness.
Macleods Pharma USA, Inc is...
04/02/2026
Pharmacy Learning Network
News
Class II Recall Issued for Poractant Alfa Over Sterility Concerns
04/02/2026
Hannah Musick
Chiesi USA, Inc is recalling select lots of CUROSURF (poractant alfa) intratracheal suspension due to lack of sterility assurance, potentially increasing the risk of contamination in a critical neonatal therapy.
Chiesi USA, Inc is recalling select lots of CUROSURF (poractant alfa) intratracheal suspension due to lack of sterility assurance, potentially increasing the risk of contamination in a critical neonatal therapy.
Chiesi USA, Inc is recalling...
04/02/2026
Pharmacy Learning Network
News
Teva Recalls Octreotide Injectable Suspensions Nationwide Over Sterility Concerns
04/02/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple lots of octreotide acetate injectable suspensions due to a lack of sterility assurance linked to manufacturing quality system deficiencies.
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple lots of octreotide acetate injectable suspensions due to a lack of sterility assurance linked to manufacturing quality system deficiencies.
The US Food and Drug...
04/02/2026
Pharmacy Learning Network
News
Dexamethasone Sodium Phosphate Injection Recalled for Impurity Levels Above Specifications
03/26/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for dexamethasone sodium phosphate injection after stability testing revealed impurity levels above acceptable limits in a widely used injectable corticosteroid.
The US Food and Drug Administration (FDA) has issued a Class II recall for dexamethasone sodium phosphate injection after stability testing revealed impurity levels above acceptable limits in a widely used injectable corticosteroid.
The US Food and Drug...
03/26/2026
Pharmacy Learning Network
News
Bottles of Children’s Ibuprofen Recalled Nationwide Over Contamination Concerns
03/19/2026
Grace Taylor, MS, MA
A nationwide recall of children’s ibuprofen oral suspension has been initiated after reports of foreign material, including gel-like masses and black particles, were found in affected bottles.
A nationwide recall of children’s ibuprofen oral suspension has been initiated after reports of foreign material, including gel-like masses and black particles, were found in affected bottles.
A nationwide recall of...
03/19/2026
Pharmacy Learning Network
News
FDA Class III Recall Issued for Pitavastatin Tablets Due to Mixed Dosage Tablet in Bottle
03/19/2026
Grace Taylor, MS, MA
A nationwide alert has been issued after a mislabeled bottle of pitavastatin was found to contain a lower-dose tablet, prompting a Class III recall affecting select inventory in Tennessee.
A nationwide alert has been issued after a mislabeled bottle of pitavastatin was found to contain a lower-dose tablet, prompting a Class III recall affecting select inventory in Tennessee.
A nationwide alert has been...
03/19/2026
Pharmacy Learning Network
News
Apotex Recalls Brimonidine/Timolol Ophthalmic Solution Over Sterility Concerns
03/19/2026
Grace Taylor, MS, MA
Apotex has voluntarily recalled over 100 000 vials of brimonidine/timolol ophthalmic solution distributed nationwide due to concerns about lack of sterility.
Apotex has voluntarily recalled over 100 000 vials of brimonidine/timolol ophthalmic solution distributed nationwide due to concerns about lack of sterility.
Apotex has voluntarily recalled...
03/19/2026
Pharmacy Learning Network
News
Midodrine Hydrochloride Under Class II Recall Due to Inadequately Sealed Blister Packaging
03/12/2026
Hannah Musick
The Harvard Drug Group LLC is recalling one lot of midodrine hydrochloride tablets nationwide due to inadequately sealed blister packaging that may compromise product integrity.
The Harvard Drug Group LLC is recalling one lot of midodrine hydrochloride tablets nationwide due to inadequately sealed blister packaging that may compromise product integrity.
The Harvard Drug Group LLC is...
03/12/2026
Pharmacy Learning Network
News
Teva Metoprolol Succinate Tablets Recalled for Failed Dissolution Specifications
03/12/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Teva’s metoprolol succinate extended-release tablets due to failed dissolution specifications, potentially affecting consistent cardiovascular...
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Teva’s metoprolol succinate extended-release tablets due to failed dissolution specifications, potentially affecting consistent cardiovascular...
The US Food and Drug...
03/12/2026
Pharmacy Learning Network
News
Cipla Nilotinib Capsules Recalled for Stability Specification Failures
03/12/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class III recall for select lots of Cipla’s nilotinib capsules after stability testing identified out-of-specification appearance and description results.
The US Food and Drug Administration (FDA) has issued a Class III recall for select lots of Cipla’s nilotinib capsules after stability testing identified out-of-specification appearance and description results.
The US Food and Drug...
03/12/2026
Pharmacy Learning Network

Subscribe Today

Pharmacy Learning Network Newsletter

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use